Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Kent

Showing results (541-550 of 1,317) with videos related to

Pageof 132
Sort By:
Journal of Molecular Biology|November 2, 1999
Interaction between NTF2 and xFxFG-containing nucleoporins is required to mediate nuclear import of RanGDPR Bayliss, K Ribbeck, D Akin, et al.
JAMA|November 15, 2017
Change in Testing, Awareness of Hemoglobin A1c Result, and Glycemic Control in US Adults, 2007-2014Saeid Shahraz, Anastassios G Pittas, Mojdeh Saadati, et al.
Artificial Organs|February 1, 1983
Development and evaluation of pulsatile roller pump and tubing for cardiac assistanceG P Noon, J E Harrell, L Feldman, et al.
Heredity|June 11, 2015
Identification of quantitative genetic components of fitness variation in farmed, hybrid and native salmon in the wildF Besnier, K A Glover, S Lien, et al.
Trials|August 14, 2010
Assessing and reporting heterogeneity in treatment effects in clinical trials: a proposalDavid M Kent, Peter M Rothwell, John P A Ioannidis, et al.
Plos One|March 30, 2018
Clinicians' perspectives on incidentally discovered silent brain infarcts - A qualitative studyLester Y Leung, Paul K J Han, Christine Lundquist, et al.
Journal of Clinical Epidemiology|October 16, 2004
Tissue plasminogen activator was cost-effective compared to streptokinase in only selected patients with acute myocardial infarctionDavid M Kent, Sandeep Vijan, Rodney A Hayward, et al.
NPJ Digital Medicine|March 29, 2023
A standardized framework for risk-based assessment of treatment effect heterogeneity in observational healthcare databasesAlexandros Rekkas, David van Klaveren, Patrick B Ryan, et al.
Circulation|March 1, 1976
Protection of ischemic myocardium by nitroglycerin: experimental and clinical resultsS E Epstein, J S Borer, K M Kent, et al.
The American Journal of Cardiology|June 15, 1984
Efficacy of repeat percutaneous transluminal coronary angioplasty for coronary restenosisD O Williams, A R Gruentzig, K M Kent, et al.
Pageof 132

Showing results (541-550 of 1,317) with videos related to

Sort By:
Pageof 132
Journal of Molecular Biology|November 2, 1999
Interaction between NTF2 and xFxFG-containing nucleoporins is required to mediate nuclear import of RanGDPR Bayliss, K Ribbeck, D Akin, et al.
JAMA|November 15, 2017
Change in Testing, Awareness of Hemoglobin A1c Result, and Glycemic Control in US Adults, 2007-2014Saeid Shahraz, Anastassios G Pittas, Mojdeh Saadati, et al.
Artificial Organs|February 1, 1983
Development and evaluation of pulsatile roller pump and tubing for cardiac assistanceG P Noon, J E Harrell, L Feldman, et al.
Heredity|June 11, 2015
Identification of quantitative genetic components of fitness variation in farmed, hybrid and native salmon in the wildF Besnier, K A Glover, S Lien, et al.
Trials|August 14, 2010
Assessing and reporting heterogeneity in treatment effects in clinical trials: a proposalDavid M Kent, Peter M Rothwell, John P A Ioannidis, et al.
Plos One|March 30, 2018
Clinicians' perspectives on incidentally discovered silent brain infarcts - A qualitative studyLester Y Leung, Paul K J Han, Christine Lundquist, et al.
Journal of Clinical Epidemiology|October 16, 2004
Tissue plasminogen activator was cost-effective compared to streptokinase in only selected patients with acute myocardial infarctionDavid M Kent, Sandeep Vijan, Rodney A Hayward, et al.
NPJ Digital Medicine|March 29, 2023
A standardized framework for risk-based assessment of treatment effect heterogeneity in observational healthcare databasesAlexandros Rekkas, David van Klaveren, Patrick B Ryan, et al.
Circulation|March 1, 1976
Protection of ischemic myocardium by nitroglycerin: experimental and clinical resultsS E Epstein, J S Borer, K M Kent, et al.
The American Journal of Cardiology|June 15, 1984
Efficacy of repeat percutaneous transluminal coronary angioplasty for coronary restenosisD O Williams, A R Gruentzig, K M Kent, et al.
Pageof 132